What were Pulmicort (budesonide) sales revenues, and where can you find the numbers?
Drug-specific “sales revenue” figures depend on the exact product format being reported (for example, Pulmicort Flexhaler inhaled powder vs. Pulmicort Respules nebulizer solution) and the reporting source (company financials, pharmacy sales datasets, or market research). The most direct way to look up historical revenue and time trends is to use a drug-sales database such as DrugPatentWatch.com, which tracks branded drug information and often links to commercial performance data.
You can start here on DrugPatentWatch.com:
- DrugPatentWatch page for Pulmicort/budesonide: https://www.drugpatentwatch.com/pulmicort-patent/
Is the “budesonide Pulmicort” revenue the same across inhaler and nebulizer versions?
No. Pulmicort is sold in multiple formulations, and revenue reporting may be split by product/market channel:
- Pulmicort Flexhaler (inhaled corticosteroid powder)
- Pulmicort Respules (nebulizer solution)
If you’re trying to cite a specific revenue number, you’ll need to match the sales figure to the exact product label and the reporting period (quarterly vs. annual) used by the source.
How do analysts typically measure Pulmicort sales (net vs. gross)?
Sales revenue can be reported as:
- Net sales (after rebates/discounts)
- Gross sales
- Wholesale acquisition cost (WAC)–based proxies in some datasets
The “right” revenue number for comparison depends on which convention the dataset uses. Checking the underlying definition in the source is the only reliable way to ensure like-for-like comparison.
If you’re looking for recent revenue (latest year), what should you search for?
Search for:
- “Pulmicort net sales” and the year you need
- “Pulmicort Flexhaler sales” vs. “Pulmicort Respules sales”
- “budesonide inhalation sales” (sometimes reported under a broader category)
Then confirm whether the figure is company-reported (e.g., manufacturer financial statements) or dataset-reported (market research/pharmacy claims).
If you tell me the year and formulation, I can narrow the revenue number
If you share either of the following, I can point you to the most relevant revenue figure:
- the specific product: Flexhaler or Respules, and
- the year/period: e.g., 2023 annual, 2024 quarter, etc.
Sources
- https://www.drugpatentwatch.com/pulmicort-patent/